Literature DB >> 2991378

cAMP is an essential signal in the induction of antibody production by B cells but inhibits helper function of T cells.

K M Gilbert, M K Hoffmann.   

Abstract

Dibutyryl cAMP and IL 1 were found to stimulate antigen-specific and polyclonal antibody production when added together to cultures of highly purified B cells. We propose that IL 1 and an elevation in cytoplasmic cAMP represent minimal signal requirements for B cell activation. In contrast to its effect on B cells, dibutyryl cAMP inhibited helper T cell activity. Cyclic AMP suppressed the production of IL 2 and T cell replacing factor (TRF) by T cells and thus abrogated the ability of helper T cells to enhance SRBC-specific antibody production by B cells. Cyclic AMP did not inhibit the generation by T cells of B cell growth factor (BCGF). BCGF, not normally detected in Con A supernatant, was found in the culture supernatant of spleen cells that were stimulated with Con A in the presence of cAMP. Our findings indicate that cAMP blocks the production of an inhibitor of BCGF activity. cAMP had no effect on the production by macrophages of IL 1.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2991378

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  9 in total

Review 1.  Sympathetic modulation of immunity: relevance to disease.

Authors:  Denise L Bellinger; Brooke A Millar; Sam Perez; Jeff Carter; Carlo Wood; Srinivasan ThyagaRajan; Christine Molinaro; Cheri Lubahn; Dianne Lorton
Journal:  Cell Immunol       Date:  2008-03-04       Impact factor: 4.868

2.  Impaired catecholaminergic signalling of B lymphocytes in patients with chronic rheumatic diseases.

Authors:  M Wahle; S Kölker; A Krause; G R Burmester; C G Baerwald
Journal:  Ann Rheum Dis       Date:  2001-05       Impact factor: 19.103

Review 3.  Cholinergic System and Its Therapeutic Importance in Inflammation and Autoimmunity.

Authors:  Namrita Halder; Girdhari Lal
Journal:  Front Immunol       Date:  2021-04-15       Impact factor: 7.561

4.  Analysis of protective immune responses to seasonal influenza vaccination in HIV-infected individuals.

Authors:  Ying Xia; Fuli Mi; Guoqiang Du; Shenghui Qin
Journal:  Hum Vaccin Immunother       Date:  2020-05-15       Impact factor: 3.452

5.  Strong adjuvant properties of cholera toxin on gut mucosal immune responses to orally presented antigens.

Authors:  N Lycke; J Holmgren
Journal:  Immunology       Date:  1986-10       Impact factor: 7.397

6.  Human cytomegalovirus-induced immunosuppression. Relationship to tumor necrosis factor-dependent release of arachidonic acid and prostaglandin E2 in human monocytes.

Authors:  M A Nokta; M I Hassan; K Loesch; R B Pollard
Journal:  J Clin Invest       Date:  1996-06-01       Impact factor: 14.808

7.  Cholera toxin discriminates between T helper 1 and 2 cells in T cell receptor-mediated activation: role of cAMP in T cell proliferation.

Authors:  E Muñoz; A M Zubiaga; M Merrow; N P Sauter; B T Huber
Journal:  J Exp Med       Date:  1990-07-01       Impact factor: 14.307

8.  Modulation of murine Peyer's patch immunoglobulin A response by enterotoxigenic Escherichia coli.

Authors:  J A Wess; T M Petro
Journal:  Infect Immun       Date:  1987-05       Impact factor: 3.441

Review 9.  The cAMP Pathway as Therapeutic Target in Autoimmune and Inflammatory Diseases.

Authors:  Verena Katharina Raker; Christian Becker; Kerstin Steinbrink
Journal:  Front Immunol       Date:  2016-03-31       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.